Day One Biopharmaceuticals

About:

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Website: https://dayonebio.com

Twitter/X: dayonebio

Top Investors: RA Capital Management, Wellington Management, Deerfield, Perceptive Advisors, Franklin Templeton

Description:

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages. The company understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine. They develop new therapies that meet the critical needs of people of all ages living with cancer starting from the biology of childhood cancer. Day One Biopharmaceuticals also focuses its efforts to bring the best medicines to families receiving the life-altering news of a new cancer diagnosis and the need for a treatment plan. It prioritizes programs that can be rapidly brought to market for both younger and older patients. The company's goal is to license and acquire the most promising products from research institutions as well as for biotechnology and pharmaceutical companies.